Catia Marzolini

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Catia Marzolini, Amalio Telenti, Laurent A. Décosterd et al. · AIDS · 2001 · 836 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

Jacques Fellay, Catia Marzolini, E. Rhiannon Meaden et al. · The Lancet · 2002 · 662 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W. Haas, Heather J. Ribaudo, Richard B. Kim et al. · PubMed · 2004 · 629 citations

Medicine, Pharmacokinetics, Pharmacology +17

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

Chantal Csajka, Catia Marzolini, Karin Fattinger et al. · Clinical Pharmacology & Therapeutics · 2003 · 267 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

Heather J. Ribaudo, David W. Haas, C. Tierney et al. · Clinical Infectious Diseases · 2006 · 221 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17